Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
Biernacki T, Sandi D, Füvesi J, Fricska-Nagy Z, Kincses TZ, Ács P, Rózsa C, Dobos E, Cseh B, Horváth L, Nagy Z, Csányi A, Kovács K, Csépány T, Vécsei L, Bencsik K; on the behalf of the study investigators. Biernacki T, et al. Among authors: dobos e. PLoS One. 2022 Apr 22;17(4):e0267346. doi: 10.1371/journal.pone.0267346. eCollection 2022. PLoS One. 2022. PMID: 35452476 Free PMC article.
Epidemiology of familial multiple sclerosis in Hungary.
Fricska-Nagy Z, Bencsik K, Rajda C, Füvesi J, Honti V, Csépány T, Dobos E, Mátyás K, Rózsa C, Komoly S, Vécsei L. Fricska-Nagy Z, et al. Among authors: dobos e. Mult Scler. 2007 Mar;13(2):260-1. doi: 10.1177/1352458506070767. Epub 2007 Jan 29. Mult Scler. 2007. PMID: 17439894
Do Hungarian multiple sclerosis care units fulfil international criteria?
Kokas Z, Sandi D, Fricska-Nagy Z, Füvesi J, Biernacki T, Köves Á, Fazekas F, Birkás AJ, Katona G, Kovács K, Milanovich D, Dobos E, Kapás I, Jakab G, Csépány T, Bense E, Mátyás K, Rum G, Szolnoki Z, Deme I, Jobbágy Z, Kriston D, Gerócs Z, Diószeghy P, Bors L, Varga A, Kerényi L, Molnár G, Kristóf P, Nagy ZÁ, Sátori M, Imre P, Péntek S, Klivényi P, Kincses ZT, Vécsei L, Bencsik K. Kokas Z, et al. Among authors: dobos e. PLoS One. 2022 Mar 3;17(3):e0264328. doi: 10.1371/journal.pone.0264328. eCollection 2022. PLoS One. 2022. PMID: 35239686 Free PMC article.
Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study.
Bencsik K, Dobos E, Jobbágy Z, Birkás AJ, Kovács K, Sátori M, Lencsés G, Bartok G, Losonczi E, Vécsei L, On Behalf Of The Teri-Real Investigators. Bencsik K, et al. Among authors: dobos e. Pharmaceuticals (Basel). 2022 May 13;15(5):598. doi: 10.3390/ph15050598. Pharmaceuticals (Basel). 2022. PMID: 35631424 Free PMC article.
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Jokubaitis V, van der Walt A, Grand'Maison F, Sola P, Ferraro D, Shaygannejad V, Alroughani R, Hupperts R, Terzi M, Boz C, Lechner-Scott J, Pucci E, Van Pesch V, Granella F, Bergamaschi R, Spitaleri D, Slee M, Vucic S, Ampapa R, McCombe P, Ramo-Tello C, Prevost J, Olascoaga J, Cristiano E, Barnett M, Saladino ML, Sanchez-Menoyo JL, Hodgkinson S, Rozsa C, Hughes S, Moore F, Shaw C, Butler E, Skibina O, Gray O, Kermode A, Csepany T, Singhal B, Shuey N, Piroska I, Taylor B, Simo M, Sirbu CA, Sas A, Butzkueven H; MSBase Study Group. Kalincik T, et al. Neurology. 2021 Feb 2;96(5):e783-e797. doi: 10.1212/WNL.0000000000011242. Epub 2020 Dec 28. Neurology. 2021. PMID: 33372028 Free PMC article.
22 results